Helios induces epigenetic silencing of IL2 gene expression in regulatory t cells

Ian Baine, Samik Basu, Rachel Ames, Rani S. Sellers, Fernando Macian-Juan

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Regulatory T cells (Tregs) play a critical role in maintaining immune tolerance and preventing autoimmune disease. Tregs express the transcription factor Foxp3, which acts as a master regulator of their differentiation and controls their capacity to suppress T cell responses. Tregs have an intrinsically anergic phenotype and do not produce IL-2 or proliferate upon stimulation ex vivo. Recent studies identified that Helios, a member of the Ikaros family of transcription factors, is expressed in Tregs. However, its specific function is not fully understood. In this study, we show that Helios regulates IL-2 production in Tregs by suppressing Il2 gene transcription. Loss of Helios in Tregs breaks their anergic phenotype and results in derepression of the Il2 locus, allowing Tregs to display increased baseline proliferation and to produce IL-2 following stimulation. Conversely, forced expression of Helios in CD4+Foxp32 T cells results in a loss of their normal ability to produce IL-2. Helios acts by binding to the Il2 promoter and inducing epigenetic modifications that include histone deacetylation. We also show that loss of Helios in Tregs results in decreased Foxp3 binding to the Il2 promoter, indicating that Helios promotes binding of Foxp3 to the Il2 promoter. Interestingly, the loss of Helios in Tregs also causes a decrease in suppressive capacity. Our results identify Helios as a key regulator of Il2 expression in Tregs, contributing to the maintenance of the anergic phenotype.

Original languageEnglish (US)
Pages (from-to)1008-1016
Number of pages9
JournalJournal of Immunology
Volume190
Issue number3
DOIs
StatePublished - Feb 1 2013

Fingerprint

Epigenomics
Interleukin-2
Gene Expression
Phenotype
Ikaros Transcription Factor
Histone Code
T-Lymphocytes
Immune Tolerance
Aptitude
Regulatory T-Lymphocytes
Autoimmune Diseases
Transcription Factors
Maintenance
Genes

ASJC Scopus subject areas

  • Immunology

Cite this

Helios induces epigenetic silencing of IL2 gene expression in regulatory t cells. / Baine, Ian; Basu, Samik; Ames, Rachel; Sellers, Rani S.; Macian-Juan, Fernando.

In: Journal of Immunology, Vol. 190, No. 3, 01.02.2013, p. 1008-1016.

Research output: Contribution to journalArticle

Baine, Ian ; Basu, Samik ; Ames, Rachel ; Sellers, Rani S. ; Macian-Juan, Fernando. / Helios induces epigenetic silencing of IL2 gene expression in regulatory t cells. In: Journal of Immunology. 2013 ; Vol. 190, No. 3. pp. 1008-1016.
@article{d9733b66b64a43b69baa1da999f6c33c,
title = "Helios induces epigenetic silencing of IL2 gene expression in regulatory t cells",
abstract = "Regulatory T cells (Tregs) play a critical role in maintaining immune tolerance and preventing autoimmune disease. Tregs express the transcription factor Foxp3, which acts as a master regulator of their differentiation and controls their capacity to suppress T cell responses. Tregs have an intrinsically anergic phenotype and do not produce IL-2 or proliferate upon stimulation ex vivo. Recent studies identified that Helios, a member of the Ikaros family of transcription factors, is expressed in Tregs. However, its specific function is not fully understood. In this study, we show that Helios regulates IL-2 production in Tregs by suppressing Il2 gene transcription. Loss of Helios in Tregs breaks their anergic phenotype and results in derepression of the Il2 locus, allowing Tregs to display increased baseline proliferation and to produce IL-2 following stimulation. Conversely, forced expression of Helios in CD4+Foxp32 T cells results in a loss of their normal ability to produce IL-2. Helios acts by binding to the Il2 promoter and inducing epigenetic modifications that include histone deacetylation. We also show that loss of Helios in Tregs results in decreased Foxp3 binding to the Il2 promoter, indicating that Helios promotes binding of Foxp3 to the Il2 promoter. Interestingly, the loss of Helios in Tregs also causes a decrease in suppressive capacity. Our results identify Helios as a key regulator of Il2 expression in Tregs, contributing to the maintenance of the anergic phenotype.",
author = "Ian Baine and Samik Basu and Rachel Ames and Sellers, {Rani S.} and Fernando Macian-Juan",
year = "2013",
month = "2",
day = "1",
doi = "10.4049/jimmunol.1200792",
language = "English (US)",
volume = "190",
pages = "1008--1016",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "3",

}

TY - JOUR

T1 - Helios induces epigenetic silencing of IL2 gene expression in regulatory t cells

AU - Baine, Ian

AU - Basu, Samik

AU - Ames, Rachel

AU - Sellers, Rani S.

AU - Macian-Juan, Fernando

PY - 2013/2/1

Y1 - 2013/2/1

N2 - Regulatory T cells (Tregs) play a critical role in maintaining immune tolerance and preventing autoimmune disease. Tregs express the transcription factor Foxp3, which acts as a master regulator of their differentiation and controls their capacity to suppress T cell responses. Tregs have an intrinsically anergic phenotype and do not produce IL-2 or proliferate upon stimulation ex vivo. Recent studies identified that Helios, a member of the Ikaros family of transcription factors, is expressed in Tregs. However, its specific function is not fully understood. In this study, we show that Helios regulates IL-2 production in Tregs by suppressing Il2 gene transcription. Loss of Helios in Tregs breaks their anergic phenotype and results in derepression of the Il2 locus, allowing Tregs to display increased baseline proliferation and to produce IL-2 following stimulation. Conversely, forced expression of Helios in CD4+Foxp32 T cells results in a loss of their normal ability to produce IL-2. Helios acts by binding to the Il2 promoter and inducing epigenetic modifications that include histone deacetylation. We also show that loss of Helios in Tregs results in decreased Foxp3 binding to the Il2 promoter, indicating that Helios promotes binding of Foxp3 to the Il2 promoter. Interestingly, the loss of Helios in Tregs also causes a decrease in suppressive capacity. Our results identify Helios as a key regulator of Il2 expression in Tregs, contributing to the maintenance of the anergic phenotype.

AB - Regulatory T cells (Tregs) play a critical role in maintaining immune tolerance and preventing autoimmune disease. Tregs express the transcription factor Foxp3, which acts as a master regulator of their differentiation and controls their capacity to suppress T cell responses. Tregs have an intrinsically anergic phenotype and do not produce IL-2 or proliferate upon stimulation ex vivo. Recent studies identified that Helios, a member of the Ikaros family of transcription factors, is expressed in Tregs. However, its specific function is not fully understood. In this study, we show that Helios regulates IL-2 production in Tregs by suppressing Il2 gene transcription. Loss of Helios in Tregs breaks their anergic phenotype and results in derepression of the Il2 locus, allowing Tregs to display increased baseline proliferation and to produce IL-2 following stimulation. Conversely, forced expression of Helios in CD4+Foxp32 T cells results in a loss of their normal ability to produce IL-2. Helios acts by binding to the Il2 promoter and inducing epigenetic modifications that include histone deacetylation. We also show that loss of Helios in Tregs results in decreased Foxp3 binding to the Il2 promoter, indicating that Helios promotes binding of Foxp3 to the Il2 promoter. Interestingly, the loss of Helios in Tregs also causes a decrease in suppressive capacity. Our results identify Helios as a key regulator of Il2 expression in Tregs, contributing to the maintenance of the anergic phenotype.

UR - http://www.scopus.com/inward/record.url?scp=84872740201&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872740201&partnerID=8YFLogxK

U2 - 10.4049/jimmunol.1200792

DO - 10.4049/jimmunol.1200792

M3 - Article

C2 - 23275607

AN - SCOPUS:84872740201

VL - 190

SP - 1008

EP - 1016

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 3

ER -